In the past 5 years, significant advances have been made in understanding the biological properties and immune functions of KCs in NAFLD, including their interactions with tissue molecules, underlying molecular mechanisms, signaling pathways, and relevant therapeutic interventions. The gene discussed is TBCE; the disease is metabolic dysfunction-associated steatotic liver disease.